Evidence map›Paper›PMID 41755630›Full record

ArticleNucleic acids research2026

Iterative design of a NAND hybrid riboswitch by deep batch Bayesian optimization.

Daniel Kelvin, Erik Kubaczka, Marianna Karava, Heinz Koeppl, Beatrix Suess

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Daniel KelvinDepartment of Biology, TU Darmstadt, Darmstadt 64287, Germany.ORCID 0000-0003-4563-6216
Erik KubaczkaDepartment of Electrical Engineering and Information Technology, TU Darmstadt, Darmstadt 64283, Germany.ORCID 0009-0005-2467-5533
Marianna KaravaDepartment of Biology, TU Darmstadt, Darmstadt 64287, Germany.ORCID 0000-0001-9147-4153
Heinz KoepplDepartment of Biology, TU Darmstadt, Darmstadt 64287, Germany.ORCID 0000-0002-8305-9379
Beatrix SuessDepartment of Biology, TU Darmstadt, Darmstadt 64287, Germany.ORCID 0000-0001-8666-6716

Funding

Deutsche Forschungsgemeinschaft CRC 902(A2)ERC-PoC 101082333Federal Ministry of Research, Technology and Space 16IS22091Hesse-LOEWE LOEWE/4a/519/05/00.003(0007)/121Hessian Ministry for Digital Strategy and Innovation S-DIW04/0013/003
6 · The paper itself

Abstract

The design of large genetic circuits requires genetic regulatory devices capable of performing complex logic operations that place no excessive metabolic burden on the host cell. Hybrid riboswitches, synthetically enhanced compact RNA elements (<100 nucleotides) that form a tertiary structure with the ability to specifically bind two different target molecules, can be used to design genetic regulators that emulate Boolean logic. When inserted into the 5' UTR of a messenger RNA, these devices can regulate translation initiation upon specific binding of one or both ligands without the need for additional auxiliary factors. The goal of this study is to design hybrid riboswitches that emulate Boolean NAND logic in yeast. We propose a novel machine learning-based design framework combining high-throughput in vivo screening and deep Bayesian optimization. Through an initial screening, we discovered a hybrid riboswitch with NAND behavior. Using batch Bayesian optimization with an ensemble neural network as surrogate, we improved the NAND functionality of our hybrid riboswitch with respect to a performance score, thereby achieving near-digital NAND behavior. With its focus on model-based and score-driven design, our proposed method can complement experiment-driven approaches by allowing fine grained adaptation of functionality, including constructs sensitive to single nucleotide changes.

Indexed as

Riboswitch5' Untranslated RegionsBayes TheoremMachine LearningNeural Networks, ComputerRNA, MessengerSaccharomyces cerevisiae5' Untranslated RegionsRiboswitchRNA, Messenger

Identifiers

PMID41755630
PMCPMC12956344

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.